Search research articles
Contact Us
Filters
Showing results (111-120 of 202) with videos related to
Page
of 21
Sort By:
Arthritis and Rheumatism
|
June 10, 2003
Predicting mortality in patients with rheumatoid arthritis
Frederick Wolfe, Kaleb Michaud, Olaf Gefeller, et al.
Arthritis Care & Research
|
July 28, 2010
Mortality in fibromyalgia: a study of 8,186 patients over thirty-five years
Frederick Wolfe, Afton L Hassett, Brian Walitt, et al.
Lancet (London, England)
|
September 28, 2010
Rheumatoid arthritis
David L Scott, Frederick Wolfe, Tom W J Huizinga
Arthritis and Rheumatism
|
April 3, 2008
Contemporary prevalence and incidence of work disability associated with rheumatoid arthritis in the US
Saralynn Allaire, Frederick Wolfe, Jingbo Niu, et al.
CNS Drugs
|
March 29, 2012
The role of antidepressants in the management of fibromyalgia syndrome: a systematic review and meta-analysis
Winfried Häuser, Frederick Wolfe, Thomas Tölle, et al.
Plos One
|
February 20, 2014
Symptoms, the nature of fibromyalgia, and diagnostic and statistical manual 5 (DSM-5) defined mental illness in patients with rheumatoid arthritis and fibromyalgia
Frederick Wolfe, Brian T Walitt, Robert S Katz, et al.
The Journal of Rheumatology
|
April 3, 2013
In memoriam - Hugh A. Smythe, 1927-2012
Murray B Urowitz, Duncan Gordon, Charles H Goldsmith, et al.
Clinical and Experimental Rheumatology
|
May 3, 2021
Fibromyalgia revisited: do latent class analyses of symptom profiles in the general population confirm 2016 fibromyalgia diagnostic criteria?
Bjarne Schmalbach, Winfried Häuser, Elmar Brähler, et al.
Plos One
|
June 10, 2016
Three-Quarters of Persons in the US Population Reporting a Clinical Diagnosis of Fibromyalgia Do Not Satisfy Fibromyalgia Criteria: The 2012 National Health Interview Survey
Brian Walitt, Robert S Katz, Martin J Bergman, et al.
Arthritis and Rheumatism
|
December 2, 2005
The disease activity score is not suitable as the sole criterion for initiation and evaluation of anti-tumor necrosis factor therapy in the clinic: discordance between assessment measures and limitations in questionnaire use for regulatory purposes
Frederick Wolfe, Kaleb Michaud, Theodore Pincus, et al.
Page
of 21
Search research articles
Search
Showing results (111-120 of 202) with videos related to
Sort By:
Page
of 21
Arthritis and Rheumatism
|
June 10, 2003
Predicting mortality in patients with rheumatoid arthritis
Frederick Wolfe, Kaleb Michaud, Olaf Gefeller, et al.
Arthritis Care & Research
|
July 28, 2010
Mortality in fibromyalgia: a study of 8,186 patients over thirty-five years
Frederick Wolfe, Afton L Hassett, Brian Walitt, et al.
Lancet (London, England)
|
September 28, 2010
Rheumatoid arthritis
David L Scott, Frederick Wolfe, Tom W J Huizinga
Arthritis and Rheumatism
|
April 3, 2008
Contemporary prevalence and incidence of work disability associated with rheumatoid arthritis in the US
Saralynn Allaire, Frederick Wolfe, Jingbo Niu, et al.
CNS Drugs
|
March 29, 2012
The role of antidepressants in the management of fibromyalgia syndrome: a systematic review and meta-analysis
Winfried Häuser, Frederick Wolfe, Thomas Tölle, et al.
Plos One
|
February 20, 2014
Symptoms, the nature of fibromyalgia, and diagnostic and statistical manual 5 (DSM-5) defined mental illness in patients with rheumatoid arthritis and fibromyalgia
Frederick Wolfe, Brian T Walitt, Robert S Katz, et al.
The Journal of Rheumatology
|
April 3, 2013
In memoriam - Hugh A. Smythe, 1927-2012
Murray B Urowitz, Duncan Gordon, Charles H Goldsmith, et al.
Clinical and Experimental Rheumatology
|
May 3, 2021
Fibromyalgia revisited: do latent class analyses of symptom profiles in the general population confirm 2016 fibromyalgia diagnostic criteria?
Bjarne Schmalbach, Winfried Häuser, Elmar Brähler, et al.
Plos One
|
June 10, 2016
Three-Quarters of Persons in the US Population Reporting a Clinical Diagnosis of Fibromyalgia Do Not Satisfy Fibromyalgia Criteria: The 2012 National Health Interview Survey
Brian Walitt, Robert S Katz, Martin J Bergman, et al.
Arthritis and Rheumatism
|
December 2, 2005
The disease activity score is not suitable as the sole criterion for initiation and evaluation of anti-tumor necrosis factor therapy in the clinic: discordance between assessment measures and limitations in questionnaire use for regulatory purposes
Frederick Wolfe, Kaleb Michaud, Theodore Pincus, et al.
Page
of 21